Skip to content

000999.SZ

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

SZSE · Healthcare · C 制造业 · CN

CNY 24.84
−0.12%
Ask drillr

Year over year

Reported trailing growth

Revenue
+21.0%
EBITDA
—
EBIT
+10.3%
EPS
-1.4%
Free cash flow
+12.4%
Operating cash flow
+21.6%

Forward estimates

Based on analyst estimates

Revenue
+1.1%
EBITDA
+32.6%
EPS
+55.1%

Three-year CAGR

Revenue
+20.5%
EBITDA
+21.0%
EBIT
+18.1%
Net income
+11.8%
EPS
-6.0%
Free cash flow
+27.3%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026